Departments of Dermatology, Cairo University, Cairo, Egypt.
J Dermatolog Treat. 2012 Feb;23(1):4-10. doi: 10.3109/09546634.2010.487887. Epub 2010 Sep 7.
The most serious side effects of systemic steroids include osteoporosis and suprarenal suppression. Many steroid regimens have been suggested to minimize these side effects; one of them is oral steroid pulse therapy.
To compare the side effects of a daily oral steroid regimen versus a weekly oral steroid pulse regimen on bone mineral density and suprarenal suppression.
Thirty patients with different skin diseases were divided into two groups: 15 for oral daily steroids (ODS) (group 1) and 15 for weekly oral pulse steroids (WOPS) (group 2). They were evaluated for bone mineral density (measured by DEXA) and suprarenal suppression (measured by serum cortisol level), morphological changes and blood sugar. Treatment was continued for 6 months to 3 years.
Cushingoid features in group 1 were observed in 73%, yet they were not detectable in group 2. Disturbed blood sugar in group 1 was 33% and 0% in group 2. The serum cortisol level was lower in patients on ODS than those on WOPS. The effect of WOPS on bone mineral density was very limited in comparison with the ODS.
Weekly oral steroid pulse therapy induces no significant bone loss and no suprarenal suppression and can be an alternative option in the treatment of chronic disorders requiring long-term oral steroid therapy.
全身性类固醇的最严重副作用包括骨质疏松症和肾上腺抑制。已经提出了许多类固醇治疗方案来最大程度地减少这些副作用;其中之一是口服类固醇脉冲疗法。
比较每日口服类固醇方案与每周口服类固醇脉冲方案对骨密度和肾上腺抑制的副作用。
将 30 名患有不同皮肤病的患者分为两组:15 名接受每日口服类固醇(ODS)(第 1 组),15 名接受每周口服脉冲类固醇(WOPS)(第 2 组)。通过 DEXA 测量骨密度和血清皮质醇水平来评估肾上腺抑制,同时评估形态变化和血糖。治疗持续 6 个月至 3 年。
第 1 组中观察到 73%的库欣样特征,但在第 2 组中无法检测到。第 1 组中有 33%的患者血糖紊乱,而第 2 组中没有。与 WOPS 相比,ODS 患者的血清皮质醇水平较低。与 ODS 相比,WOPS 对骨密度的影响非常有限。
每周口服类固醇脉冲疗法不会引起明显的骨质流失和肾上腺抑制,并且可以作为需要长期口服类固醇治疗的慢性疾病的替代选择。